Dr Luis Raez shares his overview of the WCLC World Conference on Lung Cancer 2020 meeting.

He highlights some of the key presentations from the meeting, beginning with the CodeBreak 100 trial evaluating the agent sotorasib which targets the KRAS G12C mutation.

Dr Raez also covers the TALENT study, which evaluates the effectiveness of low-dose computed tomography (LDCT) screening in non smokers, and also the LCMC3 study into neoadjuvant atezolizumab prior to lung cancer surgery.